System-wide assembly of pathways and modules hierarchically reveal metabolic mechanism of cerebral ischemia

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhu, Yan ^a,b,d   Guo, Zhili ^a,e   Zhang, Liangxiao ^f   Zhang, Yingying ^a   Chen, Yinying ^a   Nan, Jingyi ^d   Zhao, Buchang ^d   Xiao, Hongbin ^c   Wang, Zhong ^a   Wang, Yongyan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d Shanxi Buchang Pharmaceutical Co Ltd   (China)

^e ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^f INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; MALE; METABOLISM; NERVE CELL NETWORK; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BIOMARKERS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; MALE; NERVE NET; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 84949293649     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17068     Document Type: Article

References (66)

1. Banecka, M. Z. et al. Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke-pathogenic and therapeutic implications. Acta. Biochim. Pol. 59, 495-499 (2012).
2. Saikku, P. et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983-985 (1988).
3. Wick, G., Perschinka, H., Millonig, G. Atherosclerosis as an auto-immune disease: an update. Trends Immunol. 22, 665-669 (2001).
4. Koh, P. O. Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/bad signaling cascade. J. Vet. Med. Sci. 70, 1219-1223 (2008).
5. Shamloo, M., Rytter, A., Wieloch, T. Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 93, 81-88 (1999).
6. Stetler, R. A. et al. Hsp27 protects against ischemic brain injury via attenuation of a novel stress-response cascade upstream of mitochondrial cell death signaling. J. Neurosci. 28, 13038-13055 (2008).
7. Sung, J. H., Kim, M. O., Koh, P. O. Nicotinamide prevents the down-regulation of MEK/ERK/p90RSK signaling cascade in brain ischemic injury. J. Vet. Med. Sci. 74, 35-41 (2012).
8. Wang, Q., Zhang, Q. G., Wu, D. N., Yin, X. H., Zhang, G. Y. Neuroprotection of selenite against ischemic brain injury through negatively regulating early activation of ASK1/JNK cascade via activation of PI3K/AKT pathway. Acta. Pharmacol. Sin. 28, 19-27 (2007).
9. Xu, J., Li, C., Yin, X. H., Zhang, G. Y. Additive neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI-3K/Akt pathway inhibiting the ASK1-JNK cascade. Neuropharmacology. 54, 1029-1040 (2008).
10. Zhao, J., Pei, D. S., Zhang, Q. G., Zhang, G. Y. Down-regulation Cdc42 attenuates neuronal apoptosis through inhibiting MLK3/JNK3 cascade during ischemic reperfusion in rat hippocampus. Cell Signal 19, 831-843 (2007).
11. Kork, F. et al. A possible new diagnostic biomarker in early diagnosis of Alzheimer's disease. Curr. Alzheimer Res. 6, 519-524 (2009).
12. Lanza, I. R. et al. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLos One 5, e10538 (2010).
13. Bao, Y. et al. Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. J. Proteome Res. 8, 1623-1630 (2009).
14. Clayton, T. A. et al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440, 1073-1077 (2006).
15. Zeng Y. et al. A metabonomic analysis of the effect of quercetin on toxicity induced by chronic exposure to low-level dichlorvos in rat plasma. Mol. Biosyst. 10, 2643-2653 (2014).
16. Mingxing Y. et al. NMR analysis of the rat neurochemical changes induced by middle cerebral artery occlusion. Talanta 88, 136-144 (2012).
17. Jung J. Y. et al. 1H-NMR-based metabolomics study ofcerebralinfarction. Stroke 42, 1282-1288 (2011).
18. Shi S. H. et al. A Network Pharmacology Approach to Understanding the Mechanisms of Action of Traditional Medicine: Bushenhuoxue Formula for Treatment of Chronic Kidney Disease. PLoS One 9(3), e89123. doi: 10.1371/journal.pone.0089123
19. Zhong, W. et al. Modular pharmacology: the next paradigm in 234 drug discovery. Expert Opin. Drug Discov. 7, 667-677 (2012).
20. Zhong, W., Yong-yan, W. Navigating personalized medicine dependent on modular flexibility. Trends Mol. Med. 19, 393-395 (2013).
21. Gao, J. et al. Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics 26, 971-973 (2010).
22. Yu, H., Kim, P. M., Sprecher, E., Trifonov, V., Gerstein, M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput. Biol. 3, e59 (2007).
23. Wang, L. X., Xiao, H. B., Liang, X. M., Bi, K. S. Vectorial angle method for evaluating the similarity between two chromatographic fingerprints of Chinese herb. Yao Xue Xue Bao. 37, 713-717 (2002).
24. Peter, C. et al. Structure and dynamics of molecular networks: A novel paradigm of drug discovery (A comprehensive review), Pharmacol. Therapeut. 138, 333-408 (2013).
25. Felberg, R. A., Burgin, W. S., Grotta, J. C. Neuroprotection and the ischemic cascade. CNS Spectr. 5, 52-58 (2000).
26. Nesto, R. W., Kowalchuk, G. J. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am. J. Cardiol. 59, 23C-30C (1987).
27. Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., Widmer, H. R. Functions and effects of creatine in the central nervous system. Brain Res. Bull. 76, 329-343 (2008).
28. Perasso, L. et al. Therapeutic use of creatine in brain or heart ischemia: available data and future perspectives. Med. Res. Rev. 33, 336-363 (2013).
29. Klein, A. M., Ferrante, R. J. The neuroprotective role of creatine. Subcell Biochem. 46, 205-243 (2007).
30. Zhang, X. L., Zhang, T., Peng, Y., Xu, Y., Zhang, Y. H. Association between serum uric acid and short-term clinical outcome among patients with acute stroke. Zhonghua Liu Xing Bing Xue Za Zhi. 33, 529-533 (2012).
31. Heo, S. H., Lee, S. H. High levels of serum uric acid are associated with silent brain infarction. J. Neurol. Sci. 297, 6-10 (2010).
32. Brouns, R. et al. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. Clin. Chem. Lab. Med. 48, 383-390 (2010).
33. Bourrinet, P., Quevauviller, A. Prosopinine, an alkaloid from Prosopis africana (Legumineous). Its effects on the central and autonomic nervous systems. C. R. Seances Soc. Biol. Fil. 162, 1138-1140 (1968).
34. Barber, M. N. et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS One. 7, e41456 (2012).
35. Park, S., Kim, J. A., Choi, S., Suh, S. H. Superoxide is a potential culprit of caspase-3 dependent endothelial cell death induced by lysophosphatidylcholine. J. Physiol. Pharmacol. 61, 375-381 (2010).
36. Song, J. et al. Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium/mitocondrion/caspases-dependent pathway. Planta Med. 76, 433-438 (2010).
37. Goncąlves, I. et al. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler. Thromb. Vasc. Biol. 32, 1505-1512 (2012).
38. Hota, K. B., Hota, S. K., Chaurasia, O. P., Singh, S. B. Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus 22, 723-736 (2012).
39. Jalal, F. Y., Böhlke, M., Maher, T. J. Acetyl-L-carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats. Ann. N. Y. Acad. Sci. 1199, 95-104 (2010).
40. Lolic, M. M., Fiskum, G., Rosenthal, R. E. Neuroprotective effects of acetyl-L-carnitine after stroke in rats. Ann. Emerg. Med. 29, 758-765 (1997).
41. Ge, H. et al. Gamma-linolenic acid induces apoptosis and lipid peroxidation in human chronic myelogenous leukemia K562 cells. Cell Biol. Int. 33, 402-410 (2009).
42. Kapoor, R., Huang, Y. S. Gamma linolenic acid: an antiinflammatory omega-6 fatty acid. Curr. Pharm. Biotechnol. 7, 531-534 (2006).
43. Christian, B. et al. Effects of Hypothermia on Excitatory Amino Acids and Metabolism in Stroke Patients : A Microdialysis Study. Stroke 33, 519-524 (2002).
44. Walker, V., Pickard, J. D. Prostaglandins, thromboxane, leukotrienes and the cerebral circulation in health and disease. Adv. Tech. Stand. Neurosurg. 12, 3-90 (1985).
45. Leslie, J. B., Watkins, W. D. Eicosanoids in the central nervous system. J. Neurosurg. 63, 659-668 (1985).
46. Pickard, J. D. Role of prostaglandins and arachidonic acid derivatives in the coupling of cerebral blood flow to cerebral metabolism. J. Cereb. Blood Flow Metab. l, 361-384 (1981).
47. Kimura, H., Okamoto, K. & Sakai, Y. Modulatory effects of prostaglandin D2, E2, F2a on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites "in vitro". Brain Res. 330, 235-244 (1985).
48. Shoami, E., Rosenthal, J., Lavy, S. The effect of incomplete cerebral ischemia on prostaglandin levels in rat brain. Stroke 13, 494-499 (1982).
49. Kempski, O., Shoami, E., Von Lubitz, D., Hallenbeck, J. M., Feuerstein, G. Postischemic production of eicosanoids in gerbil brain. Stroke 18, 111-119 (1987).
50. Bhakoo, K. K., Crockard, H. A., Lascelles, P. C., Avery, S. F. Prostaglandin synthesis and edema formation during reperfusion following experimental brain ischemia. Stroke 15, 891-895 (1984).
51. Gaudet, R. J., Levine, L. Effect of unilateral common carotid artery occlusion on levels of prostaglandins D2, F2 and 6-ketoprostaglandin Fla in gerbil brain. Stroke 11, 648-652 (1980).
52. Cameron, R., Savita, K. Significance of Brain Tissue Oxygenation and the Arachidonic Acid Cascade in Stroke. Antioxid. Redox. Signal. 14, 1889-1903 (2011). doi: 10.1089/ars.2010.3474.
53. Bang, H. O., Dyerberg, J., Sinclair, H. M. The composition of the Eskimo food in north-western Greenland. Am. J. Clin. Nutr. 33, 2657-2661 (1980).
54. Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S., Vane, J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis Lancet 2, 117-119 (1978).
55. Robert S., In Biology and Human Behavior: The Neurological Origins of Individuality, 2nd edition, Lecture Five the Dynamics of Interacting Neurons, The Teaching Company, 19 (2005).
56. Jung, J. et al. 1H-NMR-based metabolomics study of cerebral infarction. Stroke 42, 1282-1288 (2011).
57. Olive, M. F. Interactions between taurine and ethanol in the central nervous system. Amino Acids 23 (4), 345-357 (2002).
58. Wang Y., Wang Y. G., Ma T. F., Li M., Gu S. L. Dynamic metabolites profile of cerebral ischemia/reperfusion revealed by 1H NMR-based metabolomics contributes to potential biomarkers. Int. J. Clin. Exp. Pathol. 7(7), 4067-4075 (2014).
59. Kirkwood, T. L. et al. Network theory of aging. Exp.Gerontol. 32, 395-399 (1997).
60. Hornberg, J. J. et al. Cancer: a Systems Biology disease. Biosystems 83, 81-90 (2006).
61. Csermely, P., Söti, C., Blatch, G. L. Chaperones as parts of cellular networks. Adv. Exp. Med. Biol. 594, 55-63 (2007).
62. Wang, Z., Wang, Y. Y. Modular pharmacology: deciphering the interacting structural organization of the targeted networks. Drug Discov. Today. 18, 560-566 (2013).
63. Steffen, K., Jörg, S. Two approaches for metabolic pathway analysis Trends Biotechnol. 21, 64-69 (2003).
64. De La Fuente, I. M. et al. Global self-organization of the cellular metabolic structure. PLoS One. 3, e3100 (2008).
65. Ma, W. et al. Defining network topologies that can achieve biochemical adaptation. Cell 138, 760-773 (2009).
66. Nana-Maria, G., Hans, L., Markus, R. Regulatory crosstalk of the metabolic network. Trends Biochem. Sci. 35, 220-227 (2010).